The Dividend Yield as of November 2024 (TTM) for Kinnate Biopharma Inc. (KNTE) is 0%

According to Kinnate Biopharma Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Kinnate Biopharma Inc. (KNTE) Historical Dividend Yield (quarterly & annually)

How has KNTE Dividend Yield performed in the past?

The mean historical Dividend Yield of Kinnate Biopharma Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), KNTE's Dividend Yield was at its highest in in the December 2019 quarter at 0%. The Dividend Yield was at its lowest in in the December 2019 quarter at 0%.

Kinnate Biopharma Inc. (KNTE) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Kinnate Biopharma Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kinnate Biopharma Inc. (KNTE) Average Dividend Yield

How has KNTE Dividend Yield performed in the past?

The current Dividend Yield of Kinnate Biopharma Inc. (KNTE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kinnate Biopharma Inc. (KNTE) Dividend Yield vs. Peers

How is KNTE’s Dividend Yield compared to its peers?

Kinnate Biopharma Inc.’s Dividend Yield is less than Ambrx Biopharma Inc. (0%), less than Acelyrin, Inc. (0%), less than Windtree Therapeutics, Inc. (0%), less than Palisade Bio, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Passage Bio, Inc. (0%), less than Homology Medicines, Inc. (0%), less than Generation Bio Co. (0%), less than Stoke Therapeutics, Inc. (0%), less than Gracell Biotechnologies Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Erasca, Inc. (0%), less than Kronos Bio, Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Surrozen, Inc. (0%), less than Bolt Biotherapeutics, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Keros Therapeutics, Inc. (0%), less than Kezar Life Sciences, Inc. (0%),

Build a custom stock screener for Kinnate Biopharma Inc. (KNTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kinnate Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kinnate Biopharma Inc. (KNTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kinnate Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.